Leadgene Leadgene
LeadGMP® Human IFN Gamma Protein, His Tag, E. coli
Mehr Bilder
Katalognummer

LDG013PHE-GMP

Weitere Dokumente
Paket & Preis werden geladen...
  • Spezifikationen
    • Ursprungsart

      Human

      Expressionssystem

      Escherichia coli

    • Affinitäts-Tag

      His Tag (C-term)

      Lagerpuffer

      Lyophilized from a 0.2 µm filtered solution of PBS, pH 8.0.

    • Reinheit

      >97% as determined by SDS-PAGE analysis.

      Molekulargewicht

      The protein has a calculated MW of 17.7 kDa.
      The protein migrates as 17 kDa under reducing condition (SDS-PAGE analysis).

    • Aktivität

      Measure by its ability to induce cytotoxicity in HT29 cells. The ED₅₀ for this effect is <1 ng/mL. The specific activity of recombinant human IFN gamma is approximately >1 x 10⁷ IU/mg, which is calibrated against the human IFN Gamma WHO Reference Material (NIBSC code: 87/586).

      Endotoxingehalt

      <0.05 EU per 1 µg of the protein by the LAL method.

    • Mykoplasmen

      Not detected

      Form

      Lyophilized

  • Hintergrund
    • Hintergrund

      The cytokine IFN gamma could protect cells from viral infections and belongs to the family of interferons. A lot of studies have shown that IFN gamma secreted by antigen triggered cell types, including T cells, naive CD4+ T cells, macrophages, dendritic cells, and B cells. IFN gamma plays an important role to trigger the macrophage act against a diverse group of microbial targets, and the pleiotropic molecule associated with antiproliferative, pro-apoptotic and antitumor mechanisms. Based on the effector cytokine considered as a major effector of immunity, it has been used in the treatment of several diseases.

      Synonyme

      Interferon gamma, Immune interferon

    • Uniprot ID

      P01579

      Sequenznotiz

      Gln24-Gln166

  • Anleitung
    • Rekonstitution

      It is recommended to reconstitute the lyophilized protein in sterile H₂O to a concentration not less than 0.5 mg/mL and incubate the stock solution for at least 20 min to ensure sufficient re-dissolved.

      Versand

      The product is shipped with polar packs. Upon receipt, store it immediately at -20°C or lower for long term storage.

    • Stabilität & Lagerung

      This product is stable after storage at:

      • -20°C for 12 months in lyophilized state from date of receipt.
      • -20°C or -80°C for 1 month under sterile conditions after reconstitution.

      Avoid repeated freeze/thaw cycles.

      Herstellungsspezifikationen

      LeadGMP® recombinant proteins are manufactured in ISO 13485:2016 and GMP certified facility. The processes include:

      • Animal-free reagent and laboratory
      • Manufactured and tested under GMP guideline
      • Testing and traceability of raw material
      • Records of the maintenance and equipment calibration
      • Personnel training records
      • Batch-to-batch consistency
      • Documentation of QA control and process changes
      • Manufactured and tested under an ISO 13485:2016 certified quality management system
      • Stability monitor of product shelf-life
  • Bild
    LeadGMP® Human IFN Gamma Protein, His Tag, E. coli (LDG013PHE-GMP) induces cytotoxicity in HT29 cells, with the ED50 &lt;1.0 ng/mL.

    LeadGMP® Human IFN Gamma Protein, His Tag, E. coli (LDG013PHE-GMP) induces cytotoxicity in HT29 cells, with the ED50 <1.0 ng/mL.

    SDS-PAGE analysis of LeadGMP® IFN gamma, Human

    SDS-PAGE analysis of LeadGMP® IFN gamma, Human

    1
    /
    2
    Gesamt   (2)
  • Bewertung

    Helfen Sie anderen, mehr über dieses Produkt zu erfahren. Nutzen Sie den Link unten, um Ihre Erfahrung zu teilen.

  • Publikation

    Derzeit gibt es keine Publikationen. Nutzen Sie den Link unten, um uns zu informieren.

  • Datenblatt & Dokumente
    MSDS
    Handbuch
    1
    /
    1

Haftungsausschluss:For Research Use or Further Manufacturing Only.

Diese Website verwendet Cookies wie in unserer Privacy Policy beschrieben, um Ihre Nutzererfahrung zu verbessern und Ihnen maßgeschneiderte Werbung anzubieten. Klicken Sie auf „Ich stimme zu", um zuzustimmen und fortzufahren.